Medically reviewed by Drugs.com. Last updated on Nov 23, 2023.
Applies to gabapentin: oral capsule, oral solution, oral suspension, oral tablet, oral tablet extended release 24 hr.
Serious side effects of Gabapentin
Along with its needed effects, gabapentin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking gabapentin:
More common
- Clumsiness or unsteadiness
- continuous, uncontrolled, back-and-forth, or rolling eye movements
More common in children
- Aggressive behavior or other behavior problems
- anxiety
- concentration problems and change in school performance
- crying
- depression
- false sense of well-being
- hyperactivity or increase in body movements
- rapidly changing moods
- reacting too quickly, too emotional, or overreacting
- restlessness
- suspiciousness or distrust
Less common
- Black, tarry stools
- chest pain
- chills
- cough
- depression, irritability, or other mood or mental changes
- fever
- loss of memory
- pain or swelling in the arms or legs
- painful or difficult urination
- sore throat
- sores, ulcers, or white spots on the lips or in the mouth
- swollen glands
- unusual bleeding or bruising
- unusual tiredness or weakness
Incidence not known
- Blistering, peeling, or loosening of the skin
- clay-colored stools
- coma
- confusion
- dark urine
- decreased urine output
- diarrhea
- difficult or troubled breathing
- dizziness
- fast or irregular heartbeat
- headache
- increased thirst
- irregular, fast or slow, or shallow breathing
- itching or skin rash
- joint pain
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
- loss of appetite
- muscle ache or pain
- nausea
- pale or blue lips, fingernails, or skin
- red skin lesions, often with a purple center
- red, irritated eyes
- seizures
- stomach pain
- unpleasant breath odor
- vomiting of blood
- yellow eyes or skin
Other side effects of Gabapentin
Some side effects of gabapentin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Blurred vision
- cold or flu-like symptoms
- delusions
- dementia
- hoarseness
- lack or loss of strength
- lower back or side pain
- swelling of the hands, feet, or lower legs
- trembling or shaking
Less common or rare
- Accidental injury
- appetite increased
- back pain
- body aches or pain
- burning, dry, or itching eyes
- change in vision
- change in walking and balance
- chest tightness
- clumsiness or unsteadiness
- congestion
- constipation
- cough producing mucus
- decrease in sexual desire or ability
- dryness of the mouth or throat
- earache
- excessive tearing
- eye discharge
- feeling faint, dizzy, or lightheadedness
- feeling of warmth or heat
- flushed, dry skin
- flushing or redness of the skin, especially on the face and neck
- frequent urination
- fruit-like breath odor
- impaired vision
- incoordination
- increased hunger
- increased sensitivity to pain
- increased sensitivity to touch
- increased thirst
- noise in the ears
- pain, redness, rash, swelling, or bleeding where the skin is rubbed off
- redness or swelling in the ear
- redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid
- runny nose
- sneezing
- sweating
- tender, swollen glands in the neck
- tingling in the hands and feet
- trouble sleeping
- trouble swallowing
- trouble thinking
- twitching
- unexplained weight loss
- voice changes
- vomiting
- weakness or loss of strength
- weight gain
For Healthcare Professionals
Applies to gabapentin: compounding powder, oral capsule, oral solution, oral tablet, oral tablet extended release.
General
The most common adverse reactions associated with the use of this drug were dizziness, somnolence, and peripheral edema.[Ref]
Nervous system
Very common (10% or more): Somnolence (21%), dizziness (17%), ataxia (13%)
Common (1% to 10%): Abnormal gait, incoordination, neuralgia, tremor, dysarthria, hyperkinesia, seizures, dysarthria, paresthesia, hypesthesia, coordination abnormal, increased/decreased/absent reflexes, vertigo
Uncommon (less than 1%): Hypokinesia
Rare (less than 0.1%): Movement disorders (e.g., choreoathetosis, dyskinesia, dystonia), loss of consciousness
Frequency not reported: Withdrawal precipitated seizure/status epilepticus
Postmarketing reports: Movement disorder[Ref]
Respiratory
Reports of life-threatening or fatal respiratory depression have been reported in patients taking this drug with CNS depressants including opioids, or in the setting of underlying respiratory impairment.[Ref]
Common (1% to 10%): Pharyngitis, dyspnea, cough, bronchitis, respiratory infection, rhinitis
Rare (less than 0.1%): Pulmonary thrombosis, pulmonary embolism
Frequency not reported: Pseudo-croup, hoarseness
Postmarketing reports: Respiratory depression[Ref]
Hypersensitivity
Very rare (less than 0.01%): Hypersensitivity syndrome, a systemic reaction with a variable presentation that can include fever, rash, hepatitis, lymphadenopathy, eosinophilia, and sometimes other signs and symptoms
Frequency not reported: Anaphylaxis, angioedema[Ref]
Psychiatric
There are postmarketing reports of withdrawal symptoms shortly after discontinuing this drug. The most frequently reported reactions with abrupt discontinuation have included anxiety, insomnia, nausea, pain, and sweating. Discontinuation at higher than recommended doses have been associated with agitation, disorientation and confusion. These symptoms have resolved after restarting this drug. The dependence potential of gabapentin has not been evaluated in human studies.[Ref]
Common (1% to 10%): Abnormal thinking, amnesia, depression, hostility, confusion, emotional lability, anxiety, nervousness, insomnia
Uncommon (0.1% to 1%): Mental impairment
Rare (less than 0.1%): Hallucinations
Frequency not reported: Suicidal behavior and ideation, hypomania
Postmarketing reports: Agitation, withdrawal symptoms[Ref]
Immunologic
Frequency not reported: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)[Ref]
Dermatologic
Common (1% to 10%): Abrasion, facial edema, purpura, rash, pruritus, acne
Uncommon (0.1% to 1%): Alopecia, eczema, dry skin, increased sweating, urticaria, hirsutism, seborrhea, cyst, herpes simplex
Rare (less than 0.1%): Stevens-Johnson syndrome, angioedema, erythema multiforme, drug rash (with eosinophilia and systemic symptoms), herpes zoster, skin discolor, skin papules, photosensitive reaction, psoriasis, desquamation, maceration, skin nodules, subcutaneous nodule, melanosis, skin necrosis, local swelling
Frequency not reported: Bullous pemphigoid[Ref]
Cardiovascular
Common (1% to 10%): Peripheral edema, vasodilation, dizziness, somnolence
Rare (less than 0.1%): Atrial fibrillation, heart failure, myocardial infarction, cerebrovascular accident, ventricular extrasystoles, bradycardia, premature atrial contraction, pericardial rub, heart block, pericardial effusion, pericarditis
Postmarketing reports: Cardiac arrest, chest pain, palpitation, tachycardia[Ref]
Endocrine
Rare (less than 0.1%): Hyperthyroid, hypothyroid, goiter, hypoestrogenism, ovarian failure, epididymitis, cushingoid appearance
Postmarketing reports: Breast enlargement, breast hypertrophy, gynecomastia[Ref]
Gastrointestinal
Common (1% to 10%): Diarrhea, dry mouth or throat, constipation, nausea, vomiting, dyspepsia, dental abnormalities, gingivitis, abdominal pain, flatulence
Uncommon (0.1% to 1%): Glossitis, gum hemorrhage, thirst, stomatitis, increased salivation, gastroenteritis, hemorrhoids, bloody stools, fecal incontinence
Rare (less than 0.1%): Pancreatitis, dysphagia, eructation, pancreatitis, peptic ulcer, colitis, blisters in mouth, tooth discoloration, perlèche, salivary gland enlarged, lip hemorrhage, esophagitis, hiatal hernia, hematemesis, proctitis, irritable bowel syndrome, rectal hemorrhage, esophageal spasm
Frequency not reported: Dehydration[Ref]
Genitourinary
Common (1% to 10%): Incontinence, impotence
Uncommon (0.1% to 1%): Hematuria, dysuria, urinary frequency, cystitis, urinary retention, vagin*l hemorrhage, amenorrhea, dysmenorrhea, menorrhagia
Frequency not reported: Sexual dysfunction (including changes in libido, ejacul*tion disorders, and anorg*smia)[Ref]
Hematologic
Common (1% to 10%): Leucopenia, purpura
Uncommon (0.1% to 1%): Anemia, lymphadenopathy
Rare (less than 0.1%): Thrombocytopenia, thrombophlebitis, leukocytosis, lymphocytosis, increased bleeding time
Frequency not reported: Blood creatine phosphokinase increased, coagulation defect[Ref]
Hepatic
Rare (less than 0.1%): Hepatitis, jaundice, elevated liver function tests (AST, ALT), and bilirubin, hepatomegaly, hepatotoxicity[Ref]
Metabolic
Common (1% to 10%): Weight gain, hyperglycemia
Postmarketing reports: Hyponatremia[Ref]
Musculoskeletal
Common (1% to 10%): Back pain, arthralgia, myalgia, twitching
Uncommon (0.1% to 1%): Tendonitis, arthritis, joint stiffness, joint swelling
Frequency not reported: Rhabdomyolysis, myoclonus
Postmarketing reports: Elevated creatine kinase, rhabdomyolysis[Ref]
Ocular
Common (1% to 10%): Amblyopia, conjunctivitis, diplopia, nystagmus
Uncommon (0.1% to 1%): Cataract, dry eyes, eye pain, visual field defect, photophobia, bilateral or unilateral ptosis, eye hemorrhage, hordeolum, eye twitching
Rare (less than 0.1%): Eye itching, abnormal accommodation, eye focusing problem, watery eyes, retinopathy, glaucoma, iritis, corneal disorders, lacrimal dysfunction, degenerative eye changes, blindness, retinal degeneration, miosis, chorioretinitis, strabismus[Ref]
Oncologic
Uncommon (0.1% to 1%): Breast cancer
Rare (less than 0.1%): Non-Hodgkin's lymphoma[Ref]
Other
Very common (10% or more): Fatigue (11%), fever (11%)
Common (1% to 10%): Asthenia, accidental injury, otitis media, tremor, pain
Rare (0.01% to 0.1%): Tinnitus
Very rare (less than 0.01%): Sudden unexplained death in patients with epilepsy
Frequency not reported: Sleepwalking, withdrawal symptoms, hearing loss, earache, tinnitus, inner ear infection, otitis, taste loss, unusual taste, ear fullness, perforated ear drum, sensitivity to noise, eustachian tube dysfunction, otitis externa, odd smell, labyrinthitis[Ref]
Renal
Rare (less than 0.1%): Acute renal failure[Ref]
Frequently asked questions
- Lyrica vs Gabapentin: What's the difference?
- Does gabapentin help treat nerve pain?
- Is gabapentin considered a painkiller?
- Gabapentin for dogs: Uses, side effects and dosage
- How long does withdrawal last?
- Does it cause weight gain?
- Is gabapentin safe for cats?
- How long does it take to work?
- Does it help you sleep?
More about gabapentin
- Check interactions
- Compare alternatives
- Reviews (2,531)
- Drug images
- Latest FDA alerts (4)
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: gamma-aminobutyric acid analogs
- Breastfeeding
- En español
Patient resources
- Gabapentin drug information
- Gabapentin Capsules
- Gabapentin Oral Solution
- Gabapentin Tablets (PHN)
- Gabapentin Tablets 600 mg and 800 mg
Other brands
Neurontin, Gralise, Gabarone
Professional resources
- Gabapentin monograph
- Gabapentin (FDA)
- Gabapentin Capsules (FDA)
- Gabapentin Oral Solution (FDA)
- Gabapentin Tablets (FDA)
Other brands
Neurontin, Gralise
Related treatment guides
- Back Pain
- Anxiety
- Alcohol Use Disorder
- Alcohol Withdrawal
References
1. (2001) "Product Information. Neurontin (gabapentin)." Parke-Davis
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
3. Cerner Multum, Inc. "Australian Product Information."
4. (2021) "Product Information. Horizant (gabapentin)." GlaxoSmithKline
5. (2021) "Product Information. Gralise (gabapentin)." Depomed Inc
6. Crawford P, Ghadiali E, Lane R, Blumhardt L, Chadwick D (1987) "Gabapentin as an antiepileptic drug in man." J Neurol Neurosurg Psychiatry, 50, p.682-6
7. The US, Gabapentin Study Group No. 5 (1993) "Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study." Neurology, 43, p.2292-8
8. Pittenger C, Desan PH (2007) "Gabapentin abuse, and delirium tremens upon gabapentin withdrawal." J Clin Psychiatry, 68, p.483-4
9. Ragucci MV, Cohen JM (2001) "Gabapentin-induced hypersensitivity syndrome." Clin Neuropharmacol, 24, p.103-5
10. Short C, Cooke L (1995) "Hypomania induced by gabapentin." Br J Psychiatry, 166, p.679-80
11. Tallian KB, Nahata MC, Lo W, Tsao CY (1996) "Gabapentin associated with aggressive behavior in pediatric patients with seizures." Epilepsia, 37, p.501-2
12. Sahin S, Comert A, Akin O, Ayalp S, Karsidag S (2008) "Cutaneous drug eruptions by current antiepileptics: case reports and alternative treatment options." Clin Neuropharmacol, 31, p.93-6
13. Gidal BE, Maly MM, Nemire RE, Haley K (1995) "Weight gain and gabapentin therapy." Ann Pharmacother, 29, p.1048
14. Lasso-de-la-Vega MC, Zapater P, Such J, Perez-Mateo M, Horga JF (2001) "Gabapentin-associated hepatotoxicity." Am J Gastroenterol, 96, p.3460-2
15. Zhang C, Glenn DG, Bell WL, O'donovan CA (2005) "Gabapentin-induced Myoclonus in End-stage Renal Disease." Epilepsia, 46, p.156-158
16. Reeves AL, So EL, Sharbrough FW, Krahn LE (1996) "Movement disorders associated with the use of gabapentin." Epilepsia, 37, p.988-90
17. Silvia RJ, Spitznas AL (2007) "Gabapentin-Related Changes in Renal Function: Two Case Reports." J Clin Psychopharmacol, 27, p.118-119
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circ*mstances.
Some side effects may not be reported. You may report them to the FDA.
Medical Disclaimer